anti- ADNP antibody

Este producto es parte de ADNP - Activity dependent neuroprotector homeobox protein
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti- ADNP antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00174
tested applications
ELISA, WB, IF

Description

Potential transcription factor. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation.

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

CategoryPrimary Antibodies
Immunogen Targetactivity-dependent neuroprotector homeobox
HostRabbit
Reactivityhuman,mouse,rat
Recommended DilutionWB: 1:500-1:5000; IF: 1:10-1:100
Clonalitypolyclonal
ConjugationUnconjugated
IsotypeIgG
Observed MW135 kDa
Purity≥95% as determined by SDS-PAGE
PurificationImmunogen affinity purified
Size 1100µg
Formliquid
Tested ApplicationsELISA, WB, IF
StoragePBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt IDQ9H2P0
Gene ID23394
AliasADNP, ADNP1, KIAA0784,HVDAS, MRD28
BackgroundAntibody anti-ADNP
StatusRUO
NoteThis product is for research use only.

Descripción

Activity-dependent neuroprotector homeobox protein (ADNP) is a transcription factor and neuroprotective protein essential for brain development, neurogenesis, and chromatin remodeling through interactions with SWI/SNF chromatin-remodeling complexes It regulates gene expression critical for maintaining neuronal survival, synaptic plasticity, and cognitive processes Mutations or deletions in ADNP cause ADNP syndrome (Helsmoortel-Van der Aa syndrome), a neurodevelopmental disorder marked by intellectual disability, autism spectrum disorder traits, motor dysfunction, and developmental delay ADNP is also linked to neurodegenerative diseases, including Alzheimer’s disease, where it modulates tau phosphorylation, amyloid toxicity, and neuronal resilience Dysregulation of ADNP disrupts cell cycle control, proliferation, and apoptosis pathways, leading to impaired neuronal health and cognitive decline ADNP’s broad involvement in transcriptional regulation, synaptic maintenance, and neuroprotection underscores its essential role in brain function, making it a potential therapeutic target for neurodevelopmental and neurodegenerative diseases

Related Products

EM1612

Mouse ADNP(Activity dependent neuroprotector homeobox protein) ELISA Kit

Ver Producto
FNab00174

anti- ADNP antibody

Potential transcription factor. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation.

Ver Producto
abx003409

Activity Dependent Neuroprotector Protein (ADNP) Antibody

ADNP Antibody is a Rabbit Polyclonal antibody against ADNP. Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described.

Ver Producto